Financials data is unavailable for this security.
View more
Year on year Zhong Yuan Bio-Technology Holdings Ltd 's revenues fell -28.60% from 2.33m to 1.66m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.13m to a larger loss of 2.23m.
| Gross margin | 106.30% |
|---|---|
| Net profit margin | 7.57% |
| Operating margin | 9.14% |
| Return on assets | 6.49% |
|---|---|
| Return on equity | 64.23% |
| Return on investment | 19.10% |
More ▼
Cash flow in USDView more
In 2023, Zhong Yuan Bio-Technology Holdings Ltd increased its cash reserves by 173.14%, or 176.12k. Cash Flow from Financing totalled 1.30m or 77.94% of revenues. In addition the company used 999.16k for operations while cash from investing totalled 118.13k.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0143 |
|---|---|
| Tangible book value per share | 0.0143 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.8678 |
|---|---|
| Quick ratio | 0.8309 |
| Total debt/total equity | 6.02 |
|---|---|
| Total debt/total capital | 0.8593 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -142.99%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 111.49 |
